Establishment Labs Holdings Inc. (NASDAQ:ESTA) is Rice Hall James & Associates LLC's 9th Largest Position

Rice Hall James & Associates LLC lessened its position in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 2.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 770,667 shares of the company's stock after selling 22,633 shares during the period. Establishment Labs makes up about 1.9% of Rice Hall James & Associates LLC's holdings, making the stock its 9th biggest position. Rice Hall James & Associates LLC owned 2.75% of Establishment Labs worth $35,505,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Healthcare of Ontario Pension Plan Trust Fund increased its holdings in Establishment Labs by 1.8% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 35,236 shares of the company's stock worth $1,525,000 after acquiring an additional 632 shares during the period. R Squared Ltd bought a new position in shares of Establishment Labs in the 4th quarter worth $36,000. Verition Fund Management LLC increased its holdings in shares of Establishment Labs by 22.8% in the 3rd quarter. Verition Fund Management LLC now owns 9,400 shares of the company's stock worth $407,000 after buying an additional 1,746 shares during the last quarter. HighTower Advisors LLC increased its holdings in shares of Establishment Labs by 32.5% in the 3rd quarter. HighTower Advisors LLC now owns 10,311 shares of the company's stock worth $446,000 after buying an additional 2,529 shares during the last quarter. Finally, SkyView Investment Advisors LLC increased its holdings in shares of Establishment Labs by 30.5% in the 3rd quarter. SkyView Investment Advisors LLC now owns 12,000 shares of the company's stock worth $519,000 after buying an additional 2,805 shares during the last quarter. Institutional investors own 72.91% of the company's stock.

Establishment Labs Trading Down 4.6 %

Shares of ESTA stock traded down $1.62 on Friday, hitting $33.41. 559,219 shares of the company's stock traded hands, compared to its average volume of 651,377. The company has a debt-to-equity ratio of 5.94, a quick ratio of 2.29 and a current ratio of 3.62. Establishment Labs Holdings Inc. has a one year low of $28.16 and a one year high of $60.12. The company's fifty day simple moving average is $37.89 and its 200 day simple moving average is $41.36. The stock has a market capitalization of $935.50 million, a price-to-earnings ratio of -12.95 and a beta of 1.12.

Wall Street Analysts Forecast Growth

Separately, Stephens raised shares of Establishment Labs to a "strong-buy" rating in a report on Monday, December 2nd. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Establishment Labs presently has a consensus rating of "Buy" and a consensus price target of $60.60.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.